Actionable insights straight to your inbox

Equities logo

Pressure BioSciences (PBIO) Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China

Pressure BioSciences, Inc. (PBIO) today announced that Professor Tiannan Guo's laboratory at Westlake Institute for Advanced Study

Professor Tiannan Guo’s Laboratory at Westlake Institute for Advanced Study Named First PBI Center of Excellence in China — Four Barocycler Instruments Purchased to Support Collaborative Effort

Pressure BioSciences, Inc. (PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences industry, today announced that Professor Tiannan Guo’s laboratory at Westlake Institute for Advanced Study (“WIAS”) has been named the Company’s first Center of Excellence (“CoE”) in China. Professor Guo, M.D., Ph.D. and internationally-recognized proteomics expert Professor Ruedi Aebersold (ETH-Zurich, Switzerland) are the co-developers of PCT-SWATH, a major breakthrough in high throughput proteomic sample analysis.

PCT-SWATH is a novel proteomics method that combines the unique capabilities of PBI’s patented pressure cycling technology (“PCT”) platform for sample preparation (a critical step in the research process) with the cutting-edge analytical capabilities of SCIEX’s mass spectrometry SWATH method. SCIEX, a global leader in life sciences analytical technologies, signed an exclusive co-marketing agreement with PBI in early 2016 to improve protein quantitation in complex samples. Data strongly indicate that PCT-SWATH allows scientists to reproducibly extract, identify, and quantify more proteins from complex samples types in a shorter period of time than current methods, potentially facilitating the path to earlier and superior biological insights and discoveries.

Professor Guo said: “I am honored that our laboratory at WIAS was chosen to be PBI’s first CoE in China. Having worked with this novel, enabling technology platform for many years, I believe strongly that PCT will have a significant impact in helping research scientists in China and around the world make new discoveries in multiple fields, including proteomics, genomics, lipidomics, and metabolomics.”

Professor Guo continued: “As head of the Center of Excellence in China, I look forward to being a source of information on the features and benefits of the PCT platform, in helping my colleagues to develop new uses and applications for PCT, and in being a site where others can come and learn about PCT and PCT-SWATH. I am excited about the tasks ahead — to help educate research scientists and broaden the use of the PCT platform in China, as well as in other countries in Asia and worldwide.”

Dr. Nate Lawrence, VP of Marketing and Sales at PBI, said: “We are very pleased that Professor Guo will be leading the effort to establish and then direct our first CoE in China. This Center is the first of its kind in Asia and joins our other Centers of Excellence in Europe and Australia as an important pillar in our global marketing and sales strategy. We believe Professor Guo’s vast experience with the PCT platform, his expertise in proteomics and lipidomics, and his fluency in both Chinese and English will be invaluable in helping PBI quickly and successfully expand into the large life sciences market in China.”

Dr. Lawrence continued: “We believe the Guo Center of Excellence will quickly evolve into a powerful resource for our exclusive distributor in China, Powertech Technology Company, Ltd. With the support of Professor Guo and his team, we believe that Powertech will flourish and soon become an even stronger distributor of PBI products throughout all of China.”

Mr. Richard T. Schumacher, President and CEO of PBI, said: “Although the initial purchase of four instruments and related consumables from WIAS is greatly appreciated, it is the potential impact of having our Barocycler instruments in a laboratory at one of China’s premier research institutes, led by one of the most innovative and knowledgeable PCT users in the world, that is most exciting to us. The Chinese life sciences market is one of the largest and fastest-growing in the world. We expect to rapidly expand into this critical market with help from our colleagues at WIAS. Together with our recent expansion into Europe and the hiring of our own field sales team in the U.S., we believe our marketing strategy will result in significant revenue increases, driven by a larger and more diversified global customer base.”

About Westlake Institute for Advanced Study
Westlake Institute for Advanced Study (“WIAS”) is a non-profit research institute dedicated to the advancement of natural sciences and the frontiers of engineering disciplines. Located in the beautiful Cloud Town of Xihu District, Hangzhou, China, WIAS strives to represent the scientific strength of China, to influence the nation’s future, and to promote inclusive development and progress. Laying the foundation for the future Westlake University, WIAS aims at establishing a top-level research-oriented global university. At WIAS, scientific knowledge and technological advancement are utilized to have a real life impact on the world and to benefit human beings. Leading talent with innovative spirit and capabilities are trained to become the driving force of China’s development.

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology (“UST”) to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

In the interest of full disclosure, we call the reader’s attention to the fact that, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.